FAQ

Sirturo

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2015
02420132015

Related topics

Related topics

2 relations

Broader (2)

Bedaquiline fumaratebedaquiline

Related mentions per year

Related mentions per year

2004-2018
20002005201020152020
Sirturo
bedaquiline
Bedaquiline fumarate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Pharmacokinetics of Bedaquiline in Cerebrospinal Fluid and Serum in Multidrug-Resistant Tuberculous Meningitis.
Pharmacokinetics of Bedaquiline in Cerebrospinal Fluid and Serum in Multidrug-Resistant Tuberculous Meningitis TO THE EDITOR… (More)
  • figure 1
Is this relevant?
2015
2015
Determination of MIC distribution and epidemiological cutoff values for bedaquiline and delamanid in Mycobacterium tuberculosis using the MGIT 960 system equipped with TB eXiST.
Bedaquiline (Sirturo) and delamanid (Deltyba) have recently been approved by the regulatory authorities for treatment of… (More)
Is this relevant?
2015
2015
Timing is everything for compassionate use of delamanid
To the Editor: Nature Medicine recently published a News article1 that I believe requires some clarification; the article… (More)
Is this relevant?
2015
2015
Decaprenylphosphoryl-β-d-ribose 2'-Epimerase 1 (DprE1): A Novel Therapeutic Target for the Treatment of Tuberculosis.
Title: Azaindole Compounds, Synthesis Thereof, and Methods of Using the Same Patent Application Number: WO 2015/009525 Al… (More)
Is this relevant?
Highly Cited
2014
Highly Cited
2014
Multidrug-resistant tuberculosis and culture conversion with bedaquiline.
BACKGROUND Bedaquiline (Sirturo, TMC207), a diarylquinoline that inhibits mycobacterial ATP synthase, has been associated with… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Review
2014
Review
2014
[Two news drugs (ivacaftor & bedaquiline), one biomarker (florbetapir) and a re-positioned drug (propranolol) on the market].
Among the new molecular entities approved by the EMEA and the FDA in 2012, four have caught our attention for their significant… (More)
Is this relevant?
2014
2014
As funds to sync health records dwindle, research could suffer
NATURE MEDICINE VOLUME 20 | NUMBER 11 | NOVEMBER 2014 1225 Along a stretch of road in Boston lie two hospitals within a mile of… (More)
Is this relevant?
2013
2013
First novel anti-tuberculosis drug in 40 years
89 opment organization, established in 2000 to boost research into TB drugs. Sirturo, unlike other antibiotics that attack the… (More)
  • table 1
Is this relevant?
Review
2013
Review
2013
Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
  • Maureen A. Leahy, Julia C. Martinroe, Stephen R. Spriggs, Terraye M. Starr
  • MMWR. Recommendations and reports : Morbidity and…
  • 2013
Multidrug-resistant tuberculosis (MDR TB) is caused by Mycobacterium tuberculosis that is resistant to at least isoniazid and… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2013
2013
Bedaquiline (Sirturo) for multidrug-resistant tuberculosis.
  • The Medical letter on drugs and therapeutics
  • 2013
 
Is this relevant?